Determinants of Stability for the E6 Protein of Papillomavirus Type 16

Journal of Molecular Biology

Volumn 386, Issue 4, 2009, Pages 1123-1137

  Liu, Yuqi ^a   Cherry, Jonathan J ^b   Dineen, Joseph V ^a   Androphy, Elliot J ^b   Baleja, James D ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

biophysical methods; E6; HPV; protein protein interaction; zinc binding

Indexed keywords

PROTEIN E6; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; ZINC; ZINC BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; METAL BINDING; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PAPILLOMA VIRUS; PAPILLOMA VIRUS TYPE 16; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SURFACE PLASMON RESONANCE;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 60149089457     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.01.018     Document Type: Article

References (46)

1. Dell G., and Gaston K. Human papillomaviruses and their role in cervical cancer. Cell. Mol. Life Sci. 58 (2001) 1923-1942
2. Liu Y., and Baleja J.D. Structure and function of the papillomavirus E6 protein and its interacting proteins. Front. Biosci. 13 (2008) 121-134
3. Tungteakkhun S.S., and Duerksen-Hughes P.J. Cellular binding partners of the human papillomavirus E6 protein. Arch. Virol. 153 (2008) 397-408
4. Wise-Draper T.M., and Wells S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front. Biosci. 13 (2008) 1003-1017
5. Huibregtse J.M., Scheffner M., and Howley P.M. E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harbor Symp. Quant. Biol. 59 (1994) 237-245
6. Scheffner M., Huibregtse J.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 (1993) 495-505
7. Scheffner M., Huibregtse J.M., and Howley P.M. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl Acad. Sci. USA 91 (1994) 8797-8801
8. Massimi P., Gammoh N., Thomas M., and Banks L. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene 23 (2004) 8033-8039
9. Imai Y., Tsunokawa Y., Sugimura T., and Terada M. Purification and DNA-binding properties of human papillomavirus type 16 E6 protein expressed in Escherichia coli. Biochem. Biophys. Res. Commun. 164 (1989) 1402-1410
10. Garcia-Alai M.M., Dantur K.I., Smal C., Pietrasanta L., and Prat-Gay G. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines. Biochemistry 46 (2007) 341-349
11. Nomine Y., Ristriani T., Laurent C., Lefevre J.F., Weiss E., and Trave G. A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Protein Eng. 14 (2001) 297-305
12. 2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 40 (2001) 1196-1204
13. Nomine Y., Charbonnier S., Ristriani T., Stier G., Masson M., Cavusoglu N., et al. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain. Biochemistry 42 (2003) 4909-4917
14. Kapust R.B., and Waugh D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 8 (1999) 1668-1674
15. Nomine Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckere F., et al. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol. Cell 21 (2006) 665-678
16. Degenkolbe R., Gilligan P., Gupta S., and Bernard H.U. Chelating agents stabilize the monomeric state of the zinc binding human papillomavirus 16 E6 oncoprotein. Biochemistry 42 (2003) 3868-3873
17. Esposito D., and Chatterjee D.K. Enhancement of soluble protein expression through the use of fusion tags. Curr. Opin. Biotechnol. 17 (2006) 353-358
18. Hall, J. P. (2007). Applying fusion protein technology to E. coli. Biopharm. Int. Online journal: http://biopharminternational.findpharma.com/biopharm/Article/Applying-Fusion-Protein-Technology-to-E-coli/ArticleStandard/Article/detail/423193.
19. Hammarstrom M., Hellgren N., van Den B.S., Berglund H., and Hard T. Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli. Protein Sci. 11 (2002) 313-321
20. LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F., and McCoy J.M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (N. Y.) 11 (1993) 187-193
21. Kukimoto I., Aihara S., Yoshiike K., and Kanda T. Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. Biochem. Biophys. Res. Commun. 249 (1998) 258-262
22. Lechner M.S., and Laimins L.A. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol. 68 (1994) 4262-4273
23. Zhou P., Lugovskoy A.A., and Wagner G. A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins. J. Biomol. NMR 20 (2001) 11-14
24. Huth J.R., Bewley C.A., Jackson B.M., Hinnebusch A.G., Clore G.M., and Gronenborn A.M. Design of an expression system for detecting folded protein domains and mapping macromolecular interactions by NMR. Protein Sci. 6 (1997) 2359-2364
25. Ristriani T., Masson M., Nomine Y., Laurent C., Lefevre J.F., Weiss E., and Trave G. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions. J. Mol. Biol. 296 (2000) 1189-1203
26. Be, X. Characterization of human papillomaviral E6 protein and structural studies of E6-E6AP interaction and antibody surrogate light chain with NMR. 2001. Ph.D. thesis, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA.
27. 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6. J. Biomol. NMR 31 (2005) 129-141
28. Bagby S., Tong K.I., Liu D., Alattia J.R., and Ikura M. The button test: a small scale method using microdialysis cells for assessing protein solubility at concentrations suitable for NMR. J. Biomol. NMR 10 (1997) 279-282
29. Liu Y., Liu Z., Androphy E., Chen J., and Baleja J.D. Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus. Biochemistry 43 (2004) 7421-7431
30. Liu Y., Henry G.D., Hegde R.S., and Baleja J.D. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein. Biochemistry 46 (2007) 10864-10874
31. Talis A.L., Huibregtse J.M., and Howley P.M. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273 (1998) 6439-6445
32. Be X., Hong Y., Wei J., Androphy E.J., Chen J.J., and Baleja J.D. Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry 40 (2001) 1293-1299
33. Zanier K., Charbonnier S., Baltzinger M., Nomine Y., Altschuh D., and Trave G. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J. Mol. Biol. 349 (2005) 401-412
34. Zhang Y., Dasgupta J., Ma R.Z., Banks L., Thomas M., and Chen X.S. Structures of a HPV-E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J. Virol. 87 (2007) 3618-3626
35. Thomas M., Dasgupta J., Zhang Y., Chen X., and Banks L. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates. Virology 376 (2008) 371-378
36. Charbonnier S., Stier G., Orfanoudakis G., Kieffer B., Atkinson R.A., and Trave G. Defining the minimal interacting regions of the tight junction protein MAGI-1 and HPV16 E6 oncoprotein for solution structure studies. Protein Expression Purif. 60 (2008) 64-73
37. Gronenborn A.M., Filpula D.R., Essig N.Z., Achari A., Whitlow M., Wingfield P.T., and Clore G.M. A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. Science 253 (1991) 657-661
38. Nomine Y., Ristriani T., Laurent C., Lefevre J.F., Weiss E., and Trave G. Formation of soluble inclusion bodies by HPV E6 oncoprotein fused to maltose-binding protein. Protein Expression Purif. 23 (2001) 22-32
39. Crook T., Tidy J.A., and Vousden K.H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67 (1991) 547-556
40. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., and Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA 94 (1997) 11612-11616
41. Lee S.S., Weiss R.S., and Javier R.T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA 94 (1997) 6670-6675
42. Spanos W.C., Geiger J., Anderson M.E., Harris G.F., Bossler A.D., Smith R.B., et al. Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells. Head Neck 30 (2008) 139-147
43. Beerheide W., Bernard H.U., Tan Y.J., Ganesan A., Rice W.G., and Ting A.E. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J. Natl. Cancer Inst. 91 (1999) 1211-1220
44. McCall K.A., and Fierke C.A. Colorimetric and fluorimetric assays to quantitate micromolar concentrations of transition metals. Anal. Biochem. 284 (2000) 307-315
45. Lee K.M., Androphy E.J., and Baleja J.D. A novel method for selective isotope labeling of bacterially expressed proteins. J. Biomol. NMR 5 (1995) 93-96
46. Byeon I.J., Louis J.M., and Gronenborn A.M. A protein contortionist: core mutations of GB1 that induce dimerization and domain swapping. J. Mol. Biol. 333 (2003) 141-152